A detailed history of Magnolia Capital Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Magnolia Capital Advisors LLC holds 9,256 shares of ABBV stock, worth $1.75 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
9,256
Previous 4,885 89.48%
Holding current value
$1.75 Million
Previous $889,000 78.52%
% of portfolio
0.05%
Previous 0.76%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$154.79 - $180.76 $676,587 - $790,101
4,371 Added 89.48%
9,256 $1.59 Million
Q1 2024

May 02, 2024

BUY
$159.82 - $182.1 $230,300 - $262,406
1,441 Added 41.84%
4,885 $889,000
Q4 2023

Feb 02, 2024

SELL
$137.6 - $154.97 $20,364 - $22,935
-148 Reduced 4.12%
3,444 $533,000
Q3 2023

Nov 03, 2023

BUY
$133.59 - $154.65 $6,412 - $7,423
48 Added 1.35%
3,592 $535,000
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $397 - $494
-3 Reduced 0.08%
3,544 $477,000
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $63,339 - $72,944
438 Added 14.09%
3,547 $565,000
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $430,005 - $515,689
3,109 New
3,109 $502,000
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $65,644 - $83,455
-477 Reduced 26.6%
1,316 $201,000
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $27,187 - $33,732
-206 Reduced 10.31%
1,793 $291,000
Q4 2021

Jan 26, 2022

SELL
$107.43 - $135.93 $2,470 - $3,126
-23 Reduced 1.14%
1,999 $271,000
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $215,140 - $244,217
2,022 New
2,022 $218,000
Q2 2021

Jul 29, 2021

SELL
$105.21 - $117.21 $216,416 - $241,100
-2,057 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $210,431 - $231,659
2,057 New
2,057 $223,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $335B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Magnolia Capital Advisors LLC Portfolio

Follow Magnolia Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnolia Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnolia Capital Advisors LLC with notifications on news.